Literature DB >> 12230408

Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat.

Samuel M Cohen1, Lora L Arnold, Eva Uzvolgyi, Martin Cano, Margaret St John, Shinji Yamamoto, Xiufen Lu, X Chris Le.   

Abstract

Dimethylarsinic acid (DMA(V)) is carcinogenic to the rat urinary bladder when administered at high doses in the diet or drinking water. At a dietary dose of 100 ppm (microg/g), it produces cytotoxicity within 6 h and increased proliferation (hyperplasia) by 7 days of administration. We hypothesize that formation of the reactive organic intermediate dimethylarsinous acid (DMA(III)) is involved in the induction of the cytotoxicity. To evaluate the possibility that DMA(V) administration produces urothelial toxicity and regeneration by the formation of trivalent arsenicals, 2,3-dimercaptopropane-1-sulfonic acid (DMPS, 5600 ppm), a chelator of trivalent arsenicals, was co-administered with DMA(V) (100 ppm) for 2 weeks to groups of female Fischer F344 rats. Based on light and scanning electron microscopy, and bromodeoxyuridine labeling index, DMA(V) produced cytotoxicity and regenerative hyperplasia of the urothelium which was inhibited by co-administration with DMPS. The major forms of arsenic in the 24-h urine of rats administered DMA(V) were high concentrations of DMA(V) (66.4 +/- 2.7 microM) itself and the pentavalent organic arsenical trimethylarsine oxide (TMAO) (73.2 +/- 9.5 microM). Co-administration with DMPS led to an increase in DMA(V) (507 +/- 31 microM) with a decrease in TMAO (2.8 +/- 0.4 microM) excretion. The formation of TMAO from DMA(V) mechanistically suggests formation of the intermediate trivalent metabolite, DMA(III). In a second experiment evaluating fresh void urines collected on study days 1, 71, and 175, we detected DMA(III) in the urine of DMA(V) and DMA(V) plus DMPS-treated rats at approximately micromolar concentrations. Using rat (MYP3) and human (1T1) urothelial cells, cytotoxicity for trivalent arsenicals, sodium arsenite, monomethylarsonous acid (MMA(III)), and DMA(III) was demonstrated at 0.4-4.8 microM concentrations, whereas MMA(V), DMA(V), and TMAO were cytotoxic at millimolar concentrations. The presence of DMA(III) at micromolar concentrations in the urine of rats fed 100 ppm DMA(V) suggests that DMA(III) produced in vivo may be involved in the toxic effects in the rat urinary bladder after dietary administration of DMA(V).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230408     DOI: 10.1021/tx020026z

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  18 in total

1.  Arsenic exposure and toxicology: a historical perspective.

Authors:  Michael F Hughes; Barbara D Beck; Yu Chen; Ari S Lewis; David J Thomas
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

2.  Monomethylarsonous acid induces transformation of human bladder cells.

Authors:  Tiffany G Bredfeldt; Bhumasamudram Jagadish; Kylee E Eblin; Eugene A Mash; A Jay Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2006-06-27       Impact factor: 4.219

3.  Elevated hydrostatic pressure stimulates ATP release which mediates activation of the NLRP3 inflammasome via P2X4 in rat urothelial cells.

Authors:  Cody L Dunton; J Todd Purves; Francis M Hughes; Huixia Jin; Jiro Nagatomi
Journal:  Int Urol Nephrol       Date:  2018-08-11       Impact factor: 2.370

4.  Transplacental arsenic carcinogenesis in mice.

Authors:  Michael P Waalkes; Jie Liu; Bhalchandra A Diwan
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-12       Impact factor: 4.219

5.  Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer).

Authors:  Araceli Hernández-Zavala; Tomáš Matoušek; Zuzana Drobná; David S Paul; Felecia Walton; Blakely M Adair; Dědina Jiří; David J Thomas; Miroslav Stýblo
Journal:  J Anal At Spectrom       Date:  2008       Impact factor: 4.023

6.  Transcriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer.

Authors:  Kathryn A Bailey; Kathleen Wallace; Lisa Smeester; Sheau-Fung Thai; Douglas C Wolf; Stephen W Edwards; Rebecca C Fry
Journal:  J Can Res Updates       Date:  2012-08-21

7.  Comparative oxidation state specific analysis of arsenic species by high-performance liquid chromatography-inductively coupled plasma-mass spectrometry and hydride generation-cryotrapping-atomic absorption spectrometry.

Authors:  Jenna Currier; R Jesse Saunders; Lan Ding; Wanda Bodnar; Peter Cable; Tomáš Matoušek; John T Creed; Miroslav Stýblo
Journal:  J Anal At Spectrom       Date:  2013-06-01       Impact factor: 4.023

8.  Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration.

Authors:  Michael F Hughes; Vicenta Devesa; Blakely M Adair; Sean D Conklin; John T Creed; Miroslav Styblo; Elaina M Kenyon; David J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  2007-10-22       Impact factor: 4.219

9.  The potential repertoire of the innate immune system in the bladder: expression of pattern recognition receptors in the rat bladder and a rat urothelial cell line (MYP3 cells).

Authors:  Francis M Hughes; David P Turner; J Todd Purves
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

Review 10.  Origins, fate, and actions of methylated trivalent metabolites of inorganic arsenic: progress and prospects.

Authors:  Miroslav Stýblo; Abhishek Venkatratnam; Rebecca C Fry; David J Thomas
Journal:  Arch Toxicol       Date:  2021-03-26       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.